摘要
世界正在老化,我们必须面对这带来的挑战。世界人口老龄化加剧的原因之一是预期寿命的增加,而且,由于我们的寿命更长,因此,良好的生活和预防与年龄有关的疾病至关重要。通过这种方式,提高对衰老过程及其机制的认识至关重要。理想情况下,有一组健康衰老的生物标志物,可以估计一个人的生物学年龄,这将是非常有意义的。对衰老有很大贡献的变化之一是蛋白质稳态的丧失,也被称为蛋白质平衡。为了确保细胞的正常功能和维持细胞的蛋白质平衡,生物体开发了控制蛋白质合成、折叠和降解的系统。蛋白质平衡的丧失或功能障碍是许多经过深入研究的人类神经系统疾病的根源,例如阿尔茨海默病,最近,它与衰老过程有牵连,一些报告显示长寿的动物已经改善了蛋白质平衡。越来越多的证据表明,参与蛋白质平衡和长寿的几个参与者的数量和/或活动的变化之间存在着密切的联系。在这篇综述中,我们概述了衰老的主要特征,重点是蛋白质平衡。我们介绍了衰老过程中蛋白质平衡成分的变化如何影响模型生物体的寿命。我们还简要回顾了衰老生物标记物的现状,并讨论了蛋白质平衡网络元件作为健康衰老标志的潜力。
关键词: 老化,蛋白质平衡,蛋白酶体,伴侣,蛋白质聚集物,衰老的生物标志。
Current Molecular Medicine
Title:Aging and Proteins: What Does Proteostasis Have to Do with Age?
Volume: 18 Issue: 3
关键词: 老化,蛋白质平衡,蛋白酶体,伴侣,蛋白质聚集物,衰老的生物标志。
摘要: The world is aging and we must face the challenges that this brings. One of the reasons for the increasing aging of the world’s population is the increase in life expectancy and, since we live longer, it is of paramount importance to live well and to prevent age-associated diseases. In this way, it is crucial to improve knowledge of the aging process and of the mechanisms that contribute to it. Ideally it would be of great interest to have a panel of biomarkers of healthy aging that would allow an estimate of the biological age of an individual. One of the changes that greatly contribute to aging is the loss of protein homeostasis, also called proteostasis. To ensure the proper function of cells and to maintain cellular proteostasis, organisms have developed systems to control protein synthesis, folding and degradation. Loss or dysfunction of proteostasis is at the root of many well-studied human neurological diseases, such as Alzheimer’s disease and, more recently, it has been implicated in the aging process with some reports showing long-lived animals to have improved proteostasis. Growing evidence suggests a strong link between modifications in the quantity and/or activity of several players involved in proteostasis and longevity. In this review, we give an overview of the main characteristics of aging with focus on proteostasis. We present how changes in components of proteostasis, during aging, impact the lifespan of model organisms. We also briefly review the current state of aging biomarkers and discuss the potential of proteostasis network components as markers of healthy aging.
Export Options
About this article
Cite this article as:
Aging and Proteins: What Does Proteostasis Have to Do with Age?, Current Molecular Medicine 2018; 18 (3) . https://dx.doi.org/10.2174/1566524018666180907162955
DOI https://dx.doi.org/10.2174/1566524018666180907162955 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Protective Ability of Perovskia abrotanoides Karel Root Extract on the Aggregation of Protein In Vitro
The Natural Products Journal Is Human Immunodeficiency Virus-Mediated Dementia an Autophagic Defect that Leads to Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders
Current Medicinal Chemistry Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)
Central Nervous System Agents in Medicinal Chemistry Human Cognitive and Neuro-Psychiatric Bio-Markers in the Cardiac Peri-Operative Patient
Current Molecular Medicine Recent Advances and Patents for Nerve Scaffold Biomaterials and their Use for Local, Non-Viral Delivery of Growth Factors and Nucleic Acids
Recent Patents on Biomedical Engineering (Discontinued) Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry Longevity Pathways: HSF1 and FoxO Pathways, a New Therapeutic Target to Prevent Age-Related Diseases
Current Aging Science Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways
Current Molecular Medicine Recent Advances in Liver X Receptor Biology and Chemistry
Current Topics in Medicinal Chemistry Genetic Variants in Diseases of the Extrapyramidal System
Current Genomics Dual Acting Anti-Inflammatory Drugs
Current Topics in Medicinal Chemistry Role of Free Radicals and Antioxidant Signaling in Skeletal Muscle Health and Pathology
Infectious Disorders - Drug Targets Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Subject Index To Volume 3
Current Alzheimer Research Molecular Mechanism Aspect of ER Stress in Alzheimer's Disease: Current Approaches and Future Strategies
Current Drug Targets Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience